Definitions of acute myeloid leukaemia and their clinical significance according to the WHO 2022 and ICC classification

Backhaus,  Donata; Jendro,  Jacob; Platzbecker,  Uwe; Brauer,  Dominic; Jentzsch,  Madlen

Home > Proceedings in Haematology > Proceedings of the 4th European Congress Controversies in Leukemia

Read the full Report (pdf)

The 4th European Congress Controversies in Leukemias 20-21 November 2023, Brussels, Belgium

Definitions of acute myeloid leukaemia and their clinical significance according to the WHO 2022 and ICC classification

Conference

EUROLEUK 2023

Author(s)

Backhaus et al.

Type

Proceedings article

1 May 2024 09:00

Is allogeneic transplantation necessary in acute myeloid leukaemia of intermediate risk in the first complete remission?

Conference

EUROLEUK 2023

Author(s)

Rivada et al.

Type

Proceedings article

1 May 2024 08:15

Why we should opt for continuous therapy in chronic lymphocytic leukaemia?

Conference

EUROLEUK 2023

Author(s)

Visentin

Type

Proceedings article

1 May 2024 07:49

Online First

Definitions of acute myeloid leukaemia and their clinical significance according to the WHO 2022 and ICC classification

Conference

EUROLEUK 2023

Author(s)

Backhaus et al.

Type

Proceedings article

1 May 2024 09:00

Advances and remaining challenges in adult acute lymphoblastic leukaemia

Conference

EUROLEUK 2023

Author(s)

Ottmann

Type

Proceedings article

1 May 2024 08:54

Drug-based maintenance strategies post-allogeneic stem cell transplantation – are we there yet (and will we be)?

Conference

EUROLEUK 2023

Author(s)

Fløisand

Type

Proceedings article

1 May 2024 08:50

Therapeutic strategies in TP53 AML not eligible to intensive chemotherapy

Conference

EUROLEUK 2023

Author(s)

El Murr et al.

Type

Proceedings article

1 May 2024 08:44

Is allogeneic transplantation necessary in acute myeloid leukaemia of intermediate risk in the first complete remission?

Conference

EUROLEUK 2023

Author(s)

Rivada et al.

Type

Proceedings article

1 May 2024 08:15

Immunotherapeutic strategies after allogeneic stem cell transplantation

Conference

EUROLEUK 2023

Author(s)

Spyridonidis et al.

Type

Proceedings article

1 May 2024 08:02

Why we should opt for continuous therapy in chronic lymphocytic leukaemia?

Conference

EUROLEUK 2023

Author(s)

Visentin

Type

Proceedings article

1 May 2024 07:49

Acute myeloid leukaemia: First debate on leukaemia biology

Conference

EUROLEUK 2023

Author(s)

Curti

Type

Proceedings article

30 April 2024 12:11

Therapeutic strategies in high-risk acute myeloid leukaemia eligible for intensive chemotherapy

Conference

EUROLEUK 2023

Author(s)

Cluzeau

Type

Proceedings article

30 April 2024 11:36

Medical Conferences

Proceedings of the 4th European Congress Controversies in Leukemia

Featured articles

Definitions of acute myeloid leukaemia and their clinical significance according to the WHO 2022 and ICC classification

Is allogeneic transplantation necessary in acute myeloid leukaemia of intermediate risk in the first complete remission?

Why we should opt for continuous therapy in chronic lymphocytic leukaemia?

CONTENTS

Online First

Definitions of acute myeloid leukaemia and their clinical significance according to the WHO 2022 and ICC classification

Advances and remaining challenges in adult acute lymphoblastic leukaemia

Drug-based maintenance strategies post-allogeneic stem cell transplantation – are we there yet (and will we be)?

Therapeutic strategies in TP53 AML not eligible to intensive chemotherapy

Is allogeneic transplantation necessary in acute myeloid leukaemia of intermediate risk in the first complete remission?

Immunotherapeutic strategies after allogeneic stem cell transplantation

Why we should opt for continuous therapy in chronic lymphocytic leukaemia?

Acute myeloid leukaemia: First debate on leukaemia biology

Therapeutic strategies in high-risk acute myeloid leukaemia eligible for intensive chemotherapy